Effect of Pirfenidone on TA Fibrosis

Clinical trial NCT07325357 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07325357
Sponsor: Shanghai Zhongshan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Takayasu Arteritis

Start date: 2025-12-20
Primary completion: 2028-12-31
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.